Physician profile
Glen Ross
NPI 1114985348
$83,720.80
in general payments reported to CMS, 2019-2025
34 companies · $29K in 2025
The $29K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $9,327 · 2021: $5,357 · 2022: $6,105 · 2023: $6,799 · 2024: $8,321 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $18K · Consulting Fee: $13K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $18,117.21 |
| Consulting Fee | $13,180.05 |
| Food and Beverage | $12,558.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $30,744.74 | 2020-2025 | |
| Stryker Corporation | $26,965.76 | 2019-2025 | Blueprint Patient Specific Instrumentation, 1788, Knotilus Anchor, 3.5mm |
| Arthrex, INC. | $11,189.75 | 2019-2025 | |
| Kairos Surgical INC | $2,851.84 | 2021-2025 | |
| Restor3d, INC. | $2,739.13 | 2025 | |
| Wright Medical Technology, INC. | $2,678.22 | 2019-2020 | |
| Encore Medical, Lp | $1,165.58 | 2019-2021 | |
| Smith+Nephew, INC. | $589.44 | 2019-2025 | N/A, Renasys Touch |
| Banner Surgical Solutions, INC | $512.59 | 2025 | |
| Innovation Technologies INC | $452.89 | 2021-2023 | Irrisept |
| Anika Therapeutics, INC. | $392.62 | 2020-2025 | Tactoset |
| Catalyst Orthoscience | $382.71 | 2022-2025 | Catalyst Fracture Shoulder System, Catalyst Total Csr, Archer Csr Total Shoulder System |
| Bone Support INC. | $345.74 | 2020-2024 | Cerament G, Ceramentbone Void Filler |
| Osteoremedies, LLC | $345.44 | 2024-2025 | Biobrush, Remedy Spacer, Remedy Spectrum Gv Spacer |
| Vericel Corporation | $292.55 | 2022-2024 | Maci |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $238.29 | 2019 | |
| Orthofix Medical, INC. | $237.07 | 2019-2023 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $229.34 | 2022 | |
| Zimmer Biomet Holdings, INC. | $186.92 | 2025 | Comprehensive Shoulder System |
| Linvatec Corporation | $185.11 | 2023 | Biobrace 23mm |
| Acumed LLC | $174.53 | 2019-2023 | Acumed |
| Depuy Synthes Sales INC. | $140.97 | 2023 | |
| Avanos Medical | $116.79 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $114.30 | 2025 | |
| Heron Therapeutics, INC. | $104.14 | 2024 | Zynrelef |
| Elite Orthopedics, LLC | $73.35 | 2024 | |
| Fidia Pharma USA INC. | $67.19 | 2019 | |
| Bioventus LLC | $62.14 | 2019-2021 | |
| Djo, LLC | $34.99 | 2019 | |
| Kinamed, INC. | $27.28 | 2019 | |
| Abbott Laboratories | $25.22 | 2024 | Proclaim |
| Dynasplint Systems INC. | $20.61 | 2025 | Dynasplint |
| Medacta USA, INC. | $18.76 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.